Clinical Trial Update: CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for cytoreductive surgery with HIPEC using gemcitabine and dacarbazine in uterine leiomyosarcoma; the study is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Uterine Leiomyosarcoma

Drugs mentioned

• Dacarbazine (dacarbazine)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Stanford University | Conditions: LMS - Leiomyosarcoma, Uterine Leiomyosarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING